J Neuroimmunol
-
Publication Venue For
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.. 373:577987. 2022
- The clinical need for clustered AChR cell-based assay testing of seronegative MG.. 367:577850. 2022
- Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis.. 354:577541. 2021
- Imbalance in T follicular helper cells producing IL-17 promotes pro-inflammatory responses in MuSK antibody positive myasthenia gravis.. 345:577279. 2020
- The clinical presentation and treatment of MOG antibody disease at a single academic center: A case series.. 337:577078. 2019
- Circulating microRNA plasma profile in MuSK+ myasthenia gravis.. 325:87-91. 2018
- Early predictors of rapidly evolving multiple sclerosis: A case report.. 307:42-46. 2017
- Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).. 298:181-188. 2016
- Catalytic autoantibodies against myelin basic protein (MBP) isolated from serum of autistic children impair in vitro models of synaptic plasticity in rat hippocampus.. 287:1-8. 2015
- Intravenous immunoglobulin G improves neurobehavioral and histological outcomes after traumatic brain injury in mice.. 276:112-118. 2014
- Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients.. 235:70-76. 2011
- Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism.. 227:153-161. 2010